Pro Pharma Talks

Episode Outline: Issues       - Government through NIH grants provides money for investigators to find new drugs       - PhRMA takes these findings and builds new drugs       - Taxpayers don’t benefit from innovation, but pay high prices for drugs       - Safe harbors for physicians and pharmacist who participates in studies       - Safe harbor for physicians and pharmacist who participate in studies PhRMA Issues       - Development to production is costly       - Research leads to many failures       - Patent monopolies       - Marketing is costly Remember who benefits       - Rare for counties to participate in profits of new drugs, either directly or indirectly       - Universities